Promoter holding
64.27%
OP
Oxygenta Pharmaceutical Limited - Due diligence report
A 360° intelligence report on S.S Organics: trust score, financial health, credit view, compliance, directors, growth and distress signals -…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
S.S Organics — 360° Intelligence Report
Generated from MCA filings & public records44/100
Trust Score
Caution Indicated
S.S Organics is assessed as Caution Indicated with a Trust Score of 44/100. S.S Organics is an active public limited indian non-government company incorporated in 1990, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.
Report generated on 16 Aug 2026 from the latest processed filings. Oxygenta Pharmaceutical Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreCaution Indicated
44/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
40/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
75/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
Charges position: 1 open (46.60 cr) · 5 satisfied (55.70 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 5 | 48.0 cr |
| Aurobindo Pharma Limited | 1 | 48.0 cr |
Compliance Score: 40/100 Caution Indicated
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE, EPFO, SEBI.
- Litigation present in 3 court forum(s).
- 1 auditor resignation(s) filed - latest: GOWRI SHANKAR AND ASSOCIATES on 2023-08-12.
- 1 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 75/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VEDAVATHI GANGAVARAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHANDRA MOULISWAR REDDY GANGAVARAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SIDDA REDDY KANUPARTHI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRASAD REDDY BATTINAPATLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JANARDHANA REDDY YEDDULA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| V Sai sudhakar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BALASUBBA REDDY MAMILLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DOLLY MANDHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Vankineni Sai Sudhakar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Dolly Lakhichand Mandhan | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Veera Reddy Arava | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Sharvari Swapnil Shinde | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Kumkum Bajaj | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Amireddy Venkatesu Reddy | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 14 directors on the board.
- No disqualified or deactivated DINs.
- 6 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 15 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
Key managerial personnel: CHANDRA MOULISWAR REDDY GANGAVARAM (Whole-time director) · PRASAD REDDY BATTINAPATLA (CFO) · V Sai sudhakar (CFO) · BALASUBBA REDDY MAMILLA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 65 · Distress 30
Growth signals & trust indicators
Steady revenue growth: +38% over 4 year(s).
Asset base grew 1.42 - capacity expansion.
Operating for 35+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Outside liabilities up 2.1x in a year.
Negative net worth.
Compliance score is weak (40/100).
1 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence38/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 4 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment30/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 46.60 cr already registered.
- Compliance gaps should be priced into terms.
Investor view39/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events23 May 2026
Director appointed
JANARDHANA REDDY YEDDULA (Additional Director)
Director appointed
Amireddy Venkatesu Reddy (Additional Director)
26 Nov 2025
Charge satisfied
Others
07 Nov 2025
Director appointed
PRASAD REDDY BATTINAPATLA (CFO)
19 Sep 2025
Last AGM held
Annual general meeting
12 Sep 2025
Director appointed
Kumkum Bajaj (Company Secretary)
07 Aug 2025
Charge satisfied
Others
30 Jun 2025
Charge created
Others - 46.60 cr
20 Jun 2025
Director appointed
VEDAVATHI GANGAVARAM (Director)
Director appointed
CHANDRA MOULISWAR REDDY GANGAVARAM (Whole-time director)
Director appointed
SIDDA REDDY KANUPARTHI (Director)
Director appointed
BALASUBBA REDDY MAMILLA (Whole-time director)
Director appointed
Veera Reddy Arava (Director)
Director appointed
Sharvari Swapnil Shinde (Director)
04 Apr 2025
Charge satisfied
Others
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
14 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Vindhya Pharma (India) Private Limited | U24296TG2006PTC050700 | Hyderabad, Telangana, India |
| Research Dye Chem Private Limited | U24114MH1994PTC077495 | Mumbai, Maharashtra, India |
| Dano Vaccines And Biologicals Pvt Ltd | U24231TG1984PTC005135 | Hyderabad.Andhra Pradesh, Telangana, India |
| Beva Silicones Private Limited | U24299TN2008PTC070032 | Chennai, Tamil Nadu, India |
| Indian Agro-Chem Industries Private Limited | U65990MH1995PTC090229 | Dist Thane, Maharashtra, India |
| H B R Chemicals Private Limited | U24229DL1979PTC009433 | Delhi, Delhi, India |
| Vop Flavours And Fragrances Private Limited | U24304UP2020PTC146759 | Noida, Uttar Pradesh, India |
| Supraveni Chemicals Private Limited | U02411KA2003PTC032925 | Bangalore, Karnataka, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify S.S Organics before audits and certifications: compliance score 40/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of S.S Organics: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score 65/100, margin trends, ownership structure and peer set for S.S Organics - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 44/100, distress signals and MSME payment-delay disclosures - know whether S.S Organics pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for S.S Organics - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is S.S Organics an active company?
S.S Organics has MCA status “Active” with a compliance score of 40/100 (Caution Indicated).
Is S.S Organics financially healthy?
S.S Organics has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.
Should I do business with S.S Organics?
Its overall Trust Score is 44/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls S.S Organics?
Promoters hold a minority stake - exact percentages are in the full report. 14 active director(s) are on record.
Does S.S Organics have loans or charges against its assets?
1 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.
Is S.S Organics up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 40/100 (Caution Indicated).
Is it risky to lend to S.S Organics?
Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
